AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ProBiotix Health Plc

Board/Management Information Oct 23, 2025

10296_rns_2025-10-23_90f30baa-63e2-4d2c-be0b-c82f51edb5b9.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4317E

Probiotix Health PLC

23 October 2025

23 October 2025

ProBiotix Health plc

("ProBiotix" or the "Company" or, together with its subsidiary, the "Group")

Appointment of Aquis Corporate Adviser

ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that AlbR Capital Limited has been appointed as Aquis Corporate Adviser to the Company with immediate effect.

For further information, please contact:

ProBiotix Health plc https://probiotixhealth-ir.com/
[email protected]
Steen Andersen, Chief Executive Officer

Miles Nolan, Investor Relations
AlbR Capital Limited

Aquis Corporate Adviser and Broker
Tel: 020 7469 0930

Notes to Editors:

ProBiotix is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its formation, ProBiotix has become recognised as a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals.

The Company has a singular approach: discovering ground breaking probiotics, ensuring their benefits through robust science, and bringing to market effective finished probiotic-based products for human health across the globe.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXPPGCGUUPAGPP

Talk to a Data Expert

Have a question? We'll get back to you promptly.